EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+14.87%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$6.83B
AUM Growth
+$1.02B
(+18%)
Cap. Flow
+$289M
Cap. Flow
% of AUM
4.24%
Top 10 Holdings %
Top 10 Hldgs %
21.97%
Holding
934
New
39
Increased
207
Reduced
104
Closed
35
Top Buys
| 1 |
Intel
INTC
|
$19.9M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$17.3M |
| 3 |
Sunrun
RUN
|
$16.6M |
| 4 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
$15.3M |
| 5 |
NOVA
Sunnova Energy
NOVA
|
$14.9M |
Top Sells
| 1 |
HES
Hess
HES
|
$36.7M |
| 2 |
LGI Homes
LGIH
|
$12.5M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$11.3M |
| 4 |
Cummins
CMI
|
$10.4M |
| 5 |
Merck
MRK
|
$10.2M |
Sector Composition
| 1 | Technology | 34.29% |
| 2 | Healthcare | 17.66% |
| 3 | Consumer Discretionary | 9.75% |
| 4 | Industrials | 9.46% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
351
Autolus Therapeutics
AUTL
$386M
| $1.29M | 0.02% |
195,000
| – | – |
|
|
B
352
Barrick Mining Corporation
B
$49.5B
| $1.28M | 0.02% |
70,800
| – | – |
|
353
Match Group
MTCH
$9.24B
| $1.26M | 0.02% |
+34,363
| New | +$1.26M |
|
354
Stride
LRN
$7.11B
| $1.25M | 0.02% |
21,100
-10,000
| -32% | -$594K |
|
355
Flowserve
FLS
$7.28B
| $1.25M | 0.02% |
+30,000
| New | +$1.25M |
|
356
Baker Hughes
BKR
$44.9B
| $1.23M | 0.02% |
36,000
+7,000
| +24% | +$239K |
|
357
Freeport-McMoran
FCX
$66.4B
| $1.22M | 0.02% |
28,260
-2,000
| -7% | -$86K |
|
358
Biohaven
BHVN
$1.56B
| $1.21M | 0.02% |
27,900
| – | – |
|
359
Progyny
PGNY
$1.97B
| $1.19M | 0.02% |
31,528
| – | – |
|
360
Agilent Technologies
A
$36.2B
| $1.18M | 0.02% |
8,412
| – | – |
|
361
Prudential Financial
PRU
$37.1B
| $1.17M | 0.02% |
11,224
| – | – |
|
|
DCBO
362
Docebo
DCBO
$896M
| $1.14M | 0.02% |
22,900
| – | – |
|
363
Enanta Pharmaceuticals
ENTA
$185M
| $1.13M | 0.02% |
120,000
+25,500
| +27% | +$240K |
|
364
Akero Therapeutics
AKRO
$3.53B
| $1.13M | 0.02% |
+47,000
| New | +$1.13M |
|
365
Canadian Natural Resources
CNQ
$63B
| $1.11M | 0.02% |
+34,000
| New | +$1.11M |
|
366
Ocular Therapeutix
OCUL
$2.24B
| $1.07M | 0.02% |
235,800
+77,000
| +48% | +$348K |
|
|
PXD
367
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.04M | 0.02% |
4,610
| – | – |
|
368
Verisk Analytics
VRSK
$37.9B
| $996K | 0.01% |
4,200
| – | – |
|
369
Kinross Gold
KGC
$27.6B
| $989K | 0.01% |
162,000
+53,000
| +49% | +$324K |
|
|
GAP
370
The Gap, Inc.
GAP
$8.92B
| $977K | 0.01% |
46,317
| – | – |
|
371
Bright Horizons
BFAM
$6.62B
| $950K | 0.01% |
9,933
| – | – |
|
372
Target
TGT
$41.6B
| $941K | 0.01% |
6,600
-7,613
| -54% | -$1.09M |
|
373
Packaging Corp of America
PKG
$19.4B
| $939K | 0.01% |
5,750
+1,550
| +37% | +$253K |
|
374
Axsome Therapeutics
AXSM
$6.33B
| $876K | 0.01% |
11,000
| – | – |
|
375
Laureate Education
LAUR
$4.13B
| $875K | 0.01% |
64,186
| – | – |
|